172 related articles for article (PubMed ID: 26013599)
1. Functional characterization of RAD52 as a lung cancer susceptibility gene in the 12p13.33 locus.
Lieberman R; Xiong D; James M; Han Y; Amos CI; Wang L; You M
Mol Carcinog; 2016 May; 55(5):953-63. PubMed ID: 26013599
[TBL] [Abstract][Full Text] [Related]
2. The 12p13.33/RAD52 locus and genetic susceptibility to squamous cell cancers of upper aerodigestive tract.
Delahaye-Sourdeix M; Oliver J; Timofeeva MN; Gaborieau V; Johansson M; Chabrier A; Wozniak MB; Brenner DR; Vallée MP; Anantharaman D; Lagiou P; Holcátová I; Richiardi L; Kjaerheim K; Agudo A; Castellsagué X; Macfarlane TV; Barzan L; Canova C; Thakker NS; Conway DI; Znaor A; Healy CM; Ahrens W; Zaridze D; Szeszenia-Dabrowska N; Lissowska J; Fabianova E; Mates IN; Bencko V; Foretova L; Janout V; Curado MP; Koifman S; Menezes A; Wünsch-Filho V; Eluf-Neto J; Boffetta P; Garrote LF; Serraino D; Lener M; Jaworowska E; Lubiński J; Boccia S; Rajkumar T; Samant TA; Mahimkar MB; Matsuo K; Franceschi S; Byrnes G; Brennan P; McKay JD
PLoS One; 2015; 10(3):e0117639. PubMed ID: 25793373
[TBL] [Abstract][Full Text] [Related]
3. Inherited variation at chromosome 12p13.33, including RAD52, influences the risk of squamous cell lung carcinoma.
Shi J; Chatterjee N; Rotunno M; Wang Y; Pesatori AC; Consonni D; Li P; Wheeler W; Broderick P; Henrion M; Eisen T; Wang Z; Chen W; Dong Q; Albanes D; Thun M; Spitz MR; Bertazzi PA; Caporaso NE; Chanock SJ; Amos CI; Houlston RS; Landi MT
Cancer Discov; 2012 Feb; 2(2):131-9. PubMed ID: 22585858
[TBL] [Abstract][Full Text] [Related]
4. Rad52 deficiency decreases development of lung squamous cell carcinomas by enhancing immuno-surveillance.
Lieberman R; Pan J; Zhang Q; You M
Oncotarget; 2017 May; 8(21):34032-34044. PubMed ID: 28415565
[TBL] [Abstract][Full Text] [Related]
5. New lung cancer susceptibility locus identified: significance and implications for other genome-wide association studies.
Sellers TA; Chen YA
Cancer Discov; 2012 Feb; 2(2):110-1. PubMed ID: 22585853
[TBL] [Abstract][Full Text] [Related]
6. Corrupting the DNA damage response: a critical role for Rad52 in tumor cell survival.
Lieberman R; You M
Aging (Albany NY); 2017 Jul; 9(7):1647-1659. PubMed ID: 28722656
[TBL] [Abstract][Full Text] [Related]
7. Human RECQL4 represses the RAD52-mediated single-strand annealing pathway after ionizing radiation or cisplatin treatment.
Kohzaki M; Ootsuyama A; Sun L; Moritake T; Okazaki R
Int J Cancer; 2020 Jun; 146(11):3098-3113. PubMed ID: 31495919
[TBL] [Abstract][Full Text] [Related]
8. Nickel nanoparticle-induced cell transformation: involvement of DNA damage and DNA repair defect through HIF-1α/miR-210/Rad52 pathway.
Mo Y; Zhang Y; Zhang Y; Yuan J; Mo L; Zhang Q
J Nanobiotechnology; 2021 Nov; 19(1):370. PubMed ID: 34789290
[TBL] [Abstract][Full Text] [Related]
9.
Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
Ther Adv Respir Dis; 2020; 14():1753466620918192. PubMed ID: 32401173
[TBL] [Abstract][Full Text] [Related]
10. Human somatic cells deficient for RAD52 are impaired for viral integration and compromised for most aspects of homology-directed repair.
Kan Y; Batada NN; Hendrickson EA
DNA Repair (Amst); 2017 Jul; 55():64-75. PubMed ID: 28549257
[TBL] [Abstract][Full Text] [Related]
11. Identification of an SCLC susceptibility rs7963551 genetic polymorphism in a previously GWAS-identified 12p13.33 RAD52 lung cancer risk locus in the Chinese population.
Han S; Gao F; Yang W; Ren Y; Liang X; Xiong X; Pan W; Zhou L; Zhou C; Ma F; Yang M
Int J Clin Exp Med; 2015; 8(9):16528-35. PubMed ID: 26629180
[TBL] [Abstract][Full Text] [Related]
12. Tenascin C as a novel zinc finger protein 750 target regulating the immunogenicity via DNA damage in lung squamous cell carcinoma.
Xia L; Lin H; Cao H; Lian J
BMC Cancer; 2024 May; 24(1):561. PubMed ID: 38711034
[TBL] [Abstract][Full Text] [Related]
13. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
Cramer-Morales K; Nieborowska-Skorska M; Scheibner K; Padget M; Irvine DA; Sliwinski T; Haas K; Lee J; Geng H; Roy D; Slupianek A; Rassool FV; Wasik MA; Childers W; Copland M; Müschen M; Civin CI; Skorski T
Blood; 2013 Aug; 122(7):1293-304. PubMed ID: 23836560
[TBL] [Abstract][Full Text] [Related]
14. RAD52 aptamer regulates DNA damage repair and STAT3 in BRCA1/BRCA2‑deficient human acute myeloid leukemia.
Xu Y; Lin Y; Luo Y; Yang Y; Long B; Fang Z; Liu L; Zhang J; Zhang X
Oncol Rep; 2020 Oct; 44(4):1455-1466. PubMed ID: 32945515
[TBL] [Abstract][Full Text] [Related]
15. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma.
Li Z; Guo Y; Zhou L; Ge Y; Wei L; Li L; Zhou C; Wei J; Yuan Q; Li J; Yang M
Mol Carcinog; 2015 Sep; 54(9):853-8. PubMed ID: 24729511
[TBL] [Abstract][Full Text] [Related]
16. The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.
Hromas R; Kim HS; Sidhu G; Williamson E; Jaiswal A; Totterdale TA; Nole J; Lee SH; Nickoloff JA; Kong KY
Breast Cancer Res; 2017 Nov; 19(1):122. PubMed ID: 29145865
[TBL] [Abstract][Full Text] [Related]
17. The recombination protein RAD52 cooperates with the excision repair protein OGG1 for the repair of oxidative lesions in mammalian cells.
de Souza-Pinto NC; Maynard S; Hashiguchi K; Hu J; Muftuoglu M; Bohr VA
Mol Cell Biol; 2009 Aug; 29(16):4441-54. PubMed ID: 19506022
[TBL] [Abstract][Full Text] [Related]
18. Cells expressing murine RAD52 splice variants favor sister chromatid repair.
Thorpe PH; Marrero VA; Savitzky MH; Sunjevaric I; Freeman TC; Rothstein R
Mol Cell Biol; 2006 May; 26(10):3752-63. PubMed ID: 16648471
[TBL] [Abstract][Full Text] [Related]
19. [Genetic variation in DNA repair gene RAD52 is associated with the response to platinum-based chemotherapy in SCLC patients].
Li HM; Yuan P; Yu DK; Ma F; Tan WW; Feng T; Yang J; Huang Y; Lin DX; Xu BH; Tan W
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):504-9. PubMed ID: 27531263
[TBL] [Abstract][Full Text] [Related]
20. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
Siraj AK; Al-Rasheed M; Ibrahim M; Siddiqui K; Al-Dayel F; Al-Sanea O; Uddin S; Al-Kuraya K
J Endocrinol Invest; 2008 Oct; 31(10):893-9. PubMed ID: 19092295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
